Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Analysis of domestic veterinary drug raw materials market in the 42nd week of 2021

Analysis of domestic veterinary drug raw materials market in the 42nd week of 2021

ECHEMI 2021-10-21

Special Note

1. After the API China meeting, the explosive full jump mode was launched. Amoxicillin, Ampicillin, and penicillin potassium industrial salt are still on the sidelines, and there are no quotations on the market.

2. Hot products this week: Analgin, Enrofloxacin

3. Products with large price increases include florfenicol, sulfa products, quinolone products, Paracetamol, acemetaquine, spectinomycin hydrochloride, and taurine.


Cephalosporins and Penicillins

Ceftiofur Sodium, ceftiofur hydrochloride, prices rise, ceftiofur hydrochloride 1860, ceftiofur sodium 2380

Cefquinome Sulfate, the price goes up, the supply is small, the market demand is stable, the price is 8,200

Amoxicillin, the price has risen sharply recently, the market is in a state of suspension

Amoxicillin sodium, market price 465

Potassium amoxicillin and clavulanate, strong momentum, stable trading volume

Ampicillin and ampicillin sodium are strong, the market price of ampicillin is 220, and ampicillin sodium is 280

Penicillin sodium (potassium), the price goes up, the market price of penicillin sodium is 320, the price of penicillin potassium industrial salt is more than 100, the price of the same period last year is 80, a sharp increase, the price of the same period in 2019 is 61, the overall trend is rising year by year


Aminoglycosides

The price of kanamycin monosulfate rose sharply this week. The market responded quickly. The market price was 305. The price in January of this year was 270. The price started to rise in February. The price reached 300 at the end of July. After a slight correction in August, the price continued to be high. Under the policy of stability and dual control of energy consumption, prices have repeatedly broken through. The price in the same period of 2020 is 272, and the price in the same period of 2019 is 271. As a stable product throughout the year, kanamycin monosulfate has a strong position this year.

The price of neomycin sulfate increased by 152-157 due to the market influence. The market is still showing an upward trend. The price in the third quarter remained in the range of 137-145. In recent years, market competition has been fierce. The overall operation of neomycin sulfate this year is relatively low-key. , The price trend is cautious. Under the policy of "dual energy consumption control", the price increase is relatively large, and the Asia-Pacific e-he data analysis center focuses on

Spectinomycin hydrochloride, the price rises, the market price is above 565

Gentamicin sulfate, low price

Streptomycin sulfate, the market quotation increased, and the transaction price strengthened 248-278

Apramycin sulfate, driven by various factors, increased market attention, and price continued to be concerned


Tetracycline and Chloramphenicol

Doxycycline hydrochloride continues to rise, the price is like a broken bamboo, the supply of goods is relatively balanced, the rhythm of shipments is stable, and the market price is above 700

Oxytetracycline and oxytetracycline hydrochloride are on the strong side, and market inquiries and concerns have increased. The transaction price of oxytetracycline is 82-86. Oxytetracycline hydrochloride market price 101-108

Chlortetracycline hydrochloride, up slightly, the market price is 218

Florfenicol, a hot product recently, has been low-key for a summer. Affected by intermediates and dual-control policies, manufacturers are in short supply and stopped taking orders. The trading market is reluctant to sell. The price continues to rise by leaps, and there are no goods available, which is beyond the scope of rational acceptance. , There is a phenomenon of rush for goods, the market price is more than 700, the Asia-Pacific data analysis center focuses on products


Macrolides

The price of erythromycin thiocyanate rose, and the transaction price was stable at 357-373. The price of the same period in 2020 was 340, an increase of 5.9%, the price of the same period in 2019 was 330, and the price of the same period in 2018 was 465, the peak moment.

Tylosin tartrate began to open an upward channel in the third quarter, the price was firm, rose slightly, and the market quotation exceeded 300. Tylosin is an intermediate of many products, and its price changes have caused a chain reaction. The price in the same period in 2020 is 235, the price in the same period in 2019 is 240, and the price in the same period in 2018 is 415.

Lincomycin hydrochloride was stable and weak, and the transaction price ranged from 332 to 345. The price was strong in the first half of the year. In the second half of the year, affected by the market, the price was slightly weak, and the price continued to fall after August.

The price of colistin sulfate continues to rise at a high level. The market price is around 115. It is a bulk product with a large terminal consumption and active market transactions. The current price is stable at a high level. The price of the same period in 2020 is 104, the price of the same period in 2019 is 95.

Tiamulin fumarate is operating on a strong side, and the rising range has narrowed. The market reaction is dull and rational, and the transaction volume has not risen significantly. The current price is 295-315. The average price in January was 262, rose to 320 in February, 346 in March, 325 in April, and 308 in May. The price continued to fall in June, reaching a low of 260. In July, it began to strengthen at 275. In August, the price rose to 298. In September The price is around 300, under the dual control policy, singing all the way.

Tyvanin tartrate, high volatility, sufficient upstream supply, weak terminal market demand, wide market quotation range, transaction price 750-790, the market transaction price in mid-December last year was 625, the supply began to be tight in the second half of the year, and the price rose straightly and continued. By the end of March this year, the supply of goods has been eased. After April, the supply of goods has increased. The transaction price in May was 800-826. In June, the price fluctuated at a high level. The price declined in July. The price has remained stable since August.

Tilmicosin, Tilmicosin Phosphate, the prices have been raised, and market transactions are active. Tilmicosin quotations are above 460, the price of 345 in the same period in 2020, and the price in 2019 is 341; the market quotation of Tilmicosin phosphate is above 410, an increase from the previous month 8.1%, the price of the same period in 2020 is 325, a year-on-year increase of 28.2%


Sulfonamides and Quinolones

Sulfonamide products rose collectively, and sulfamonomethoxine sodium rose sharply. Under the tight raw materials and the dual control policy, the continuous jump has become unstoppable, and the supply of goods is tight, and the spot must be king. Asia-Pacific Yihe Data Analysis Center focuses on products

Sulfadiazine (sodium), the price rises, affected by the production capacity, the quotation increased by 265, the price of the same period last year was 245

Sulfamethazine (sodium), the transaction price goes up, the market price is 115

Sulfamethoxazole (sodium), the price has increased greatly

Sulfonamide versus methoxypyrimidine (sodium), strong operation and active trading

Sulfamonomethoxine (sodium), affected by various factors such as raw material intermediates, has a large price increase, and market transactions are active. The quoted price is 360-385. The overall performance this year is strong. Affected by intermediates, upstream manufacturers maintain low inventories, the overall market supply is tight, and prices continue to run at a high level. Recently, affected by the market and policies, prices have strengthened again and supply has become more tight.

Sulfachloropyrazine sodium, the price went up, the transaction price was 372, the price of the same period last year was basically the same in the range of 365-370, and the price of the same period in 2019 was 385

Sulfachlordazine Sodium, the market is stable and the price is high, the market price is 342, an increase of 11.9% year-on-year

Sulfaquinoxaline Sodium, the price is rising, the market price is above 370

The prices of trimethoprim and trimethoprim lactate have increased significantly. The transaction price of trimethoprim lactate is a mystery, with a price of 179 in the same period last year; the market quotation of trimethoprim has exceeded 250, 235 in the same period last year, an increase of 6.9%

Ditrimethoprim (DVD), the price is too strong to run 385

Prices of quinolone products remained high, manufacturers stopped reporting, and the trading market responded quickly. Affected by the "dual control of energy consumption" and limited production, manufacturers have increased their ex-factory prices twice in September.

Enrofloxacin and enrofloxacin hydrochloride prices are firm, enrofloxacin quotations have increased, and low-priced inventories have decreased. The market quotation is above 245, and the price of enrofloxacin in the same period last year was 205, an increase of 19.5%.

The prices of ciprofloxacin lactate and ciprofloxacin hydrochloride went up, the market price was 240, a year-on-year increase of 17.2%, and the price in the same period of 2019 was 195

Sarafloxacin hydrochloride, the price goes up

Marbofloxacin, price strength

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.